0000946486-19-000001.txt : 20190103
0000946486-19-000001.hdr.sgml : 20190103
20190103170631
ACCESSION NUMBER: 0000946486-19-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20190103
DATE AS OF CHANGE: 20190103
EFFECTIVENESS DATE: 20190103
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: WINDTREE THERAPEUTICS INC /DE/
CENTRAL INDEX KEY: 0000946486
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 943171943
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-329589
FILM NUMBER: 19506720
BUSINESS ADDRESS:
STREET 1: 2600 KELLY ROAD
STREET 2: SUITE 100
CITY: WARRINGTON
STATE: PA
ZIP: 18976
BUSINESS PHONE: 2154889300
MAIL ADDRESS:
STREET 1: 2600 KELLY ROAD
STREET 2: SUITE 100
CITY: WARRINGTON
STATE: PA
ZIP: 18976
FORMER COMPANY:
FORMER CONFORMED NAME: DISCOVERY LABORATORIES INC /DE/
DATE OF NAME CHANGE: 19971201
FORMER COMPANY:
FORMER CONFORMED NAME: ANSAN PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19961121
FORMER COMPANY:
FORMER CONFORMED NAME: ANSAN INC
DATE OF NAME CHANGE: 19950609
D
1
primary_doc.xml
X0708
D
LIVE
0000946486
WINDTREE THERAPEUTICS INC /DE/
2600 KELLY ROAD
SUITE 100
WARRINGTON
PA
PENNSYLVANIA
18976
2154889300
DELAWARE
DISCOVERY LABORATORIES INC /DE/
ANSAN PHARMACEUTICALS INC
ANSAN INC
Corporation
true
Craig
E.
Fraser
2600 Kelly Road
Suite 100
Warrington
PA
PENNSYLVANIA
18976
Executive Officer
Director
John
R.
Leone
2600 Kelly Road
Suite 100
Warrington
PA
PENNSYLVANIA
18976
Director
Joseph
M.
Mahady
2600 Kelly Road
Suite 100
Warrington
PA
PENNSYLVANIA
18976
Director
Bruce
A.
Peacock
2600 Kelly Road
Suite 100
Warrington
PA
PENNSYLVANIA
18976
Director
James
Huang
2600 Kelly Road
Suite 100
Warrington
PA
PENNSYLVANIA
18976
Director
Kathryn
Cole
2600 Kelly Road
Suite 100
Warrington
PA
PENNSYLVANIA
18976
Executive Officer
George
Cox
2600 Kelly Road
Suite 100
Warrington
PA
PENNSYLVANIA
18976
Executive Officer
Steven
A.
Simonson
2600 Kelly Road
Suite 100
Warrington
PA
PENNSYLVANIA
18976
Executive Officer
John
A.
Tattory
2600 Kelly Road
Suite 100
Warrington
PA
PENNSYLVANIA
18976
Executive Officer
Mary
B.
Templeton
2600 Kelly Road
Suite 100
Warrington
PA
PENNSYLVANIA
18976
Executive Officer
Lawrence
A.
Weinstein
2600 Kelly Road
Suite 100
Warrington
PA
PENNSYLVANIA
18976
Executive Officer
Brian
Schreiber
2600 Kelly Road
Suite 100
Warrington
PA
PENNSYLVANIA
18976
Director
Biotechnology
Decline to Disclose
- 06b
false
2018-12-21
false
true
true
true
0
1000000
1000000
0
false
1
0
0
0
Proceeds will fund activities to transition Istaroxime to phase 3, AEROSURF bridge study activities, Rostafuroxin clinical development, activities related to cardiovascular and KL4 pipeline programs, and general working capital purposes.
false
WINDTREE THERAPEUTICS INC /DE/
Mary B. Templeton
Mary B. Templeton
SVP, General Counsel
2019-01-03